Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Collet

Showing results (301-310 of 376) with videos related to

Pageof 38
Sort By:
American Heart Journal|June 5, 2020
Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trialPaul Guedeney, Holger Thiele, Mathieu Kerneis, et al.
Clinical Cardiology|December 17, 2017
Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registryEtienne Puymirat, Romain Didier, Hélène Eltchaninoff, et al.
The American Journal of Cardiology|October 9, 2007
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary interventionMarzia Lotrionte, Giuseppe G L Biondi-Zoccai, Pierfrancesco Agostoni, et al.
European Heart Journal|October 25, 2011
Antiplatelet agents for the treatment and prevention of atherothrombosisCarlo Patrono, Felicita Andreotti, Harald Arnesen, et al.
Archives of Cardiovascular Diseases|May 6, 2014
Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY)Grégoire Rangé, Komlavi Yayehd, Loic Belle, et al.
Lancet (London, England)|August 23, 2011
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trialGilles Montalescot, Uwe Zeymer, Johanne Silvain, et al.
European Heart Journal|August 30, 2011
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC), Michal Tendera, Victor Aboyans, et al.
Archives of Cardiovascular Diseases|October 2, 2023
The France PCI registry: Design, methodology and key findingsGrégoire Rangé, Pascal Motreff, Hakim Benamer, et al.
Medicine|September 15, 2022
Early survival after acute myocardial infarction with ST-segment elevation: What could be improved? Insights from France PCI French registryBenjamin Duband, Pascal Motreff, Pierre Marcollet, et al.
Journal of Thrombosis and Thrombolysis|November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
Pageof 38

Showing results (301-310 of 376) with videos related to

Sort By:
Pageof 38
American Heart Journal|June 5, 2020
Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trialPaul Guedeney, Holger Thiele, Mathieu Kerneis, et al.
Clinical Cardiology|December 17, 2017
Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registryEtienne Puymirat, Romain Didier, Hélène Eltchaninoff, et al.
The American Journal of Cardiology|October 9, 2007
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary interventionMarzia Lotrionte, Giuseppe G L Biondi-Zoccai, Pierfrancesco Agostoni, et al.
European Heart Journal|October 25, 2011
Antiplatelet agents for the treatment and prevention of atherothrombosisCarlo Patrono, Felicita Andreotti, Harald Arnesen, et al.
Archives of Cardiovascular Diseases|May 6, 2014
Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY)Grégoire Rangé, Komlavi Yayehd, Loic Belle, et al.
Lancet (London, England)|August 23, 2011
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trialGilles Montalescot, Uwe Zeymer, Johanne Silvain, et al.
European Heart Journal|August 30, 2011
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC), Michal Tendera, Victor Aboyans, et al.
Archives of Cardiovascular Diseases|October 2, 2023
The France PCI registry: Design, methodology and key findingsGrégoire Rangé, Pascal Motreff, Hakim Benamer, et al.
Medicine|September 15, 2022
Early survival after acute myocardial infarction with ST-segment elevation: What could be improved? Insights from France PCI French registryBenjamin Duband, Pascal Motreff, Pierre Marcollet, et al.
Journal of Thrombosis and Thrombolysis|November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
Pageof 38